B Cell Response and Mechanisms of Antibody Protection to West Nile Virus
West Nile virus (WNV) has become the principal cause of viral encephalitis in North America since its introduction in New York in 1999. This emerging virus is transmitted to humans via the bite of an infected mosquito. While there have been several candidates in clinical trials, there are no approve...
Main Authors: | S. Kyle Austin, Kimberly A. Dowd |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-03-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/6/3/1015 |
Similar Items
-
Zika virus infection confers protection against West Nile virus challenge in mice<subtitle>Zika virus protects against West Nile virus</subtitle>
by: Ángela Vázquez-Calvo, et al.
Published: (2017-01-01) -
West Nile virus: characterization and diagnostic applications of monoclonal antibodies
by: Lelli Davide, et al.
Published: (2012-04-01) -
West Nile virus vaccines – current situation and future directions
by: Sebastian Ulbert
Published: (2019-10-01) -
West Nile Virus Vaccination Protects against Usutu Virus Disease in Mice
by: Rebecca Salgado, et al.
Published: (2021-11-01) -
Development and evaluation of neutralizing antibodies for cross-protection against West Nile virus and Japanese encephalitis virus
by: Meng-Jie Yang, et al.
Published: (2023-09-01)